PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
3.56%
Cash & equivalents yoy growth 0-5% – slight improvement. Peter Lynch would verify if this aligns with revenue trends and if working capital remains healthy.
-100.00%
Declining short-term investments could free up capital but reduces near-liquid buffer. Philip Fisher would examine if this supports growth or signals cash constraints.
3.51%
Cash + STI yoy growth 0-5% – slight gain. Peter Lynch would verify if the firm's operational cash flow sustains normal expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.27%
Growth 5-10% – moderate improvement. Seth Klarman would verify if the rise aligns with revenue expansion.
11.32%
Net PP&E growth 10-20% yoy – strong investment in physical assets. Warren Buffett examines if returns on these assets meet the cost of capital.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Declining other non-current assets simplifies the balance sheet. Seth Klarman would favor this reduction in complexity.
-18.41%
Declining non-current assets may signal asset sales or underinvestment. Howard Marks would investigate future growth implications.
No Data
No Data available this quarter, please select a different quarter.
6.14%
5-10% yoy – moderate asset buildup. Seth Klarman sees typical reinvestment, verifying synergy with sales/earnings growth.
65.90%
AP up over 5% yoy – potential sign of delayed payments or aggressive working capital management. Philip Fisher demands clarity on vendor terms vs. revenue expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
126.86%
Above 5% yoy – potential spike in near-term liabilities. Philip Fisher demands details on these obligations.
114.06%
Above 15% yoy – a notable jump. Philip Fisher demands clarity on how short-term liabilities are managed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
114.06%
Above 10% yoy – large jump. Philip Fisher demands clarity on whether growth justifies the leverage.
5.13%
Above 5% yoy – more significant share issuance. Philip Fisher demands a strong ROI or else it's dilution.
-6.19%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
-12.13%
Declining AOCI may indicate reduced unrealized gains or currency losses. Howard Marks would see this as potentially reducing volatility.
-100.00%
Declining other equity items simplifies the capital structure. Benjamin Graham would favor this reduction in complexity.
-4.02%
Declining stockholders equity may signal losses or large distributions. Seth Klarman would investigate the underlying causes and sustainability.
6.14%
3-8% yoy – moderate. Seth Klarman sees typical expansions. Evaluate capital deployment.
-100.00%
Declining total investments may signal portfolio liquidation or limited opportunities. Benjamin Graham would investigate strategic focus.
No Data
No Data available this quarter, please select a different quarter.
-2.49%
Declining net debt indicates improving liquidity or deleveraging. Howard Marks would see this as strengthening financial position.